j2d3
Joined 13 years ago
Joined 13 years ago
https://github.com/s3tools/s3cmd/blob/master/s3cmd#L2048
The version I have with the typo is 1.5.0-alpha1
Pretty funny typo ;)
http://www.nybooks.com/articles/archives/2011/dec/22/world-b...
I say all this to suggest that it's not a waste of taxpayer money by uninformed politicians... no - the politicians are very well informed.
Why would a company not test a technology that may well benefit both infected and uninfected people on both populations? You would only have more data. It will take much longer to see the results if you are only studying it as a preventative measure because you have to wait (a really long time, I would suspect) to see which of your study ends up getting HIV. Additionally, you'd need to study those that do get HIV (if some do, and some probably would, as even the best vaccines aren't 100% effective) and try to see if you can tell if their infection progresses differently or if it is somehow augmented by the vaccination's boost to the immune system. I mean... your explanation doesn't actually make that much sense to me.
Why not test both populations?
http://www.livescience.com/18107-hiv-therapeutic-vaccines-pr...
according to that article there are 34 million people already infected worldwide.
Since the Immunity Project concept relies on training the immune system to mount a successful response against HIV, why would it not present some benefit to an already-infected person whose infection is otherwise controlled with drugs?
You may just be focusing on the preventative aspect, but there are many millions worldwide who are concerned with controlling HIV without depending on expensive antiviral drugs that in many cases are completely unavailable.